Pancreatic Cancer Stem-like Cells Display Aggressive Behavior Mediated via Activation of FoxQ1
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pancreatic Cancer Stem-like Cells Display Aggressive Behavior Mediated via Activation of FoxQ1
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 289, Issue 21, Pages 14520-14533
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2014-04-10
DOI
10.1074/jbc.m113.532887
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Folate Receptor Alpha: A New Tool in the Diagnosis and Treatment of Lung Cancer
- (2015) Laura D. Wood Oncotarget
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression
- (2013) Limin Xia et al. HEPATOLOGY
- A galactosidase-responsive doxorubicin-folate conjugate for selective targeting of acute myelogenous leukemia blasts
- (2013) Jonathan Clarhaut et al. LEUKEMIA RESEARCH
- FoxQ1 Promotes Glioma Cells Proliferation and Migration by Regulating NRXN3 Expression
- (2013) Hong-Tao Sun et al. PLoS One
- Increased expression of FOXQ1 is a prognostic marker for patients with gastric cancer
- (2013) Shu-Hui Liang et al. TUMOR BIOLOGY
- Pancreatic cancer stem cells: Emerging target for designing novel therapy
- (2012) Yiwei Li et al. CANCER LETTERS
- Lin28 regulates BMP4 and functions with Oct4 to affect ovarian tumor microenvironment
- (2012) Wei Ma et al. CELL CYCLE
- FoxQ1 Overexpression Influences Poor Prognosis in Non-Small Cell Lung Cancer, Associates with the Phenomenon of EMT
- (2012) Jian Feng et al. PLoS One
- Bone morphogenetic protein 4—a fascinating regulator of cancer cell behavior
- (2012) Anne Kallioniemi Cancer Genetics
- EZH2 Is Required for Breast and Pancreatic Cancer Stem Cell Maintenance and Can Be Used as a Functional Cancer Stem Cell Reporter
- (2012) Lilian E. van Vlerken et al. Stem Cells Translational Medicine
- Forkhead Transcription Factor Foxq1 Promotes Epithelial–Mesenchymal Transition and Breast Cancer Metastasis
- (2011) Haijun Zhang et al. CANCER RESEARCH
- Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression
- (2011) B. Bao et al. CANCER RESEARCH
- Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significance
- (2011) Michael D'Angelica et al. MODERN PATHOLOGY
- Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
- (2011) Bin Bao et al. PLoS One
- FOXQ1 Is Overexpressed in Colorectal Cancer and Enhances Tumorigenicity and Tumor Growth
- (2010) H. Kaneda et al. CANCER RESEARCH
- Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF
- (2010) Shadan Ali et al. CANCER RESEARCH
- Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells
- (2010) Dejuan Kong et al. PLoS One
- Cancer stem cells in solid tumors
- (2010) Patrick C. Hermann et al. SEMINARS IN CANCER BIOLOGY
- Low Doses of Bone Morphogenetic Protein 4 Increase the Survival of Human Adipose-Derived Stem Cells Maintaining Their Stemness and Multipotency
- (2010) María A. Vicente López et al. STEM CELLS AND DEVELOPMENT
- Hedgehog Target Genes: Mechanisms of Carcinogenesis Induced by Aberrant Hedgehog Signaling Activation
- (2009) Y. Katoh et al. CURRENT MOLECULAR MEDICINE
- Pancreatic cancer stem cells – insights and perspectives
- (2009) Patrick C Hermann et al. EXPERT OPINION ON BIOLOGICAL THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now